These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12081763)

  • 21. Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients.
    Minervini A; Lilas L; Minervini R; Selli C
    Cancer; 2002 May; 94(10):2590-5. PubMed ID: 12173325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.
    Rioux-Leclercq N; Delcros JG; Bansard JY; Epstein JI; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Moulinoux JP
    Hum Pathol; 2004 Oct; 35(10):1279-84. PubMed ID: 15492997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of nuclear grade of renal cell carcinoma.
    Bretheau D; Lechevallier E; de Fromont M; Sault MC; Rampal M; Coulange C
    Cancer; 1995 Dec; 76(12):2543-9. PubMed ID: 8625083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
    Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
    J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma.
    Nativ O; Sabo E; Raviv G; Medalia O; Moskovitz B; Goldwasser B
    Cancer; 1995 Oct; 76(8):1440-4. PubMed ID: 8620421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
    Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
    Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of morphometry in low grade papillary urothelial bladder neoplasms.
    Ramos D; Ruiz A; Morell L; Navarro S; Villamón R; Gil-Salom M; Llombart-Bosch A
    Anal Quant Cytol Histol; 2004 Oct; 26(5):285-94. PubMed ID: 15560535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Nuclear Morphometry and Ki-67 Index in Clear Cell Renal Cell Carcinomas: a Five-Year Study.
    Sheela Devi CS; Suchitha S; Veerendrasagar RS
    Iran J Pathol; 2017; 12(2):150-157. PubMed ID: 29515637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival analysis of surgically treated renal cell carcinoma: an analysis of 10-year data from single center].
    Zhang YS; Yu HY; Dong F; Li HZ
    Zhonghua Wai Ke Za Zhi; 2016 Jul; 54(7):528-33. PubMed ID: 27373480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ; Nagi AH; Naseem N
    Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
    Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
    Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma.
    Murphy GF; Partin AW; Maygarden SJ; Mohler JL
    J Urol; 1990 Jun; 143(6):1103-7. PubMed ID: 2342168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.